Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (2)
  • Glucocorticoid Receptor
    (2)
  • Adrenergic Receptor
    (1)
  • Carbonic Anhydrase
    (1)
  • Endothelin Receptor
    (1)
  • TRP/TRPV Channel
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cardiovascular System
    (1)
  • Endocrine system
    (1)
  • Metabolism
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

deoxycorticosterone acetate

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | All_Pathways
  • Natural Products
    2
    TargetMol | Natural_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
Deoxycorticosterone acetate
DOC acetate, Cortexone acetate, 11-Deoxycorticosterone acetate
T303356-47-3
Deoxycorticosterone acetate (DOCA) is a steroid hormone produced by the adrenal glands, possessing mineralocorticoid activity and serving as a precursor to aldosterone. As an agonist of the mineralocorticoid receptor, DOCA can induce severe kidney damage, including inflammation, fibrosis, glomerular injury, and proteinuria. It is commonly used to establish animal models of chronic kidney injury and hypertension.
  • $30
In Stock
Size
QTY
Deoxycorticosterone acetate (Standard)
TMSM-089256-47-3
Deoxycorticosterone acetate (Standard) is the standard substance of Deoxycorticosterone acetate, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Deoxycorticosterone acetate (DOCA) is a steroid hormone produced by the adrenal glands, possessing mineralocorticoid activity and serving as a precursor to aldosterone. As an agonist of the mineralocorticoid receptor, DOCA can induce severe kidney damage, including inflammation, fibrosis, glomerular injury, and proteinuria. It is commonly used to establish animal models of chronic kidney injury and hypertension.
  • $73
7-10 days
Size
QTY
GFB-8438
T113942304549-73-1
GFB-8438 is a potent and subtype selective inhibitor of TRPC5(IC50s of 0.18 and 0.29 μM of hTRPC5 and hTRPC4, respectively).
  • $30
In Stock
Size
QTY
BMS 182874
BMS-182874, BMS182874
T26841153042-42-3
BMS 182874 is an orally effective and highly selective endothelin receptor ETA antagonist with an IC50 value of 0.150 μM for ETA and a Ki value of 0.055 μM for ETA.BMS 182874 is able to reduce arterial pressure in a rat hypertension model induced by Deoxycorticosterone acetate. BMS 182874 was able to reduce Deoxycorticosterone-induced arterial pressure in a rat model of hypertension and can be used to study cardiovascular disease.
  • $30
In Stock
Size
QTY
Chlorthalidone Impurity G
T3587616289-13-7
Chlorthalidone impurity G is a potential impurity found in commercial preparations of chlorthalidone that has moderate antihypertensive effects. Chlorthalidone is a thiazide-like diuretic that inhibits the Na+/Cl- cotransporter in the distal convoluted tubule of the kidney, which prevents reabsorption of sodium and chloride leading to a reduction in plasma volume and cardiac output. It also inhibits carbonic anhydrase (CA), including the isoforms CAVB, VII, IX, XII, and XIII (Kis = 2.8-23 nM) and, to a lesser extent, CAI, CAII, IV, VA, and VI (Kis = 138-1,347 nM), which may mediate its sustained vasodilatory activity. Dietary administration of chlorthalidone (8 mg per animal per day) reduces arterial hypertension and prevents or reduces ventricular hypertrophy induced by deoxycorticosterone acetate (DOCA) in salt-hypertensive rats. Formulations containing chlorthalidone have been used alone or in combination with other antihypertensive agents to lower arterial blood pressure and as adjuvants to address edema caused by cardiac or renal disorders.
  • Inquiry Price
35 days
Size
QTY